Member Info for mizman

I'm holding for news over the next few weeks. We will be producing 100k test next month. That would require at least several RNA's that will rerate the price.

Holding for £1 plus.

100k test in August will stop the manipulation and the traders. Big money will be moving in and SP will respond.

Leave the doomsters to it.

Very disingenuous post. On the cusp of huge orders and sustained good news and you are talking ****e.

It does say home testing kits. Could be part of validation.

"Since then the Company announced a significant milestone for the UK RTC test development (ie design freeze) and so Omega now has even greater confidence in bringing the test to market as planned. As mentioned in the recent Company presentation, Omega has potentially a strong and consistent news flow over the coming months which will confirm not only progress with Omega's COVID opportunities but also with their core business as well. Significant news that expect would increase shareholder value would be confirmation of a supply agreement with the UK Government, followed by successful CE marking and approval of the UK RTC lateral flow product, as well as news of commercial traction for the Mologic tests. The company, and the Consortium, are working hard to deliver these."

Bumped from this morning. My email with Paul :

"As regards to the significant news that would increase the shareholder value, can you put a timline on each? This is particularly important to shareholders as you intend to produce 200k a week by August, so I assume that you anticipate government supply agreement, CE mark and approval in July/August? The same with the Mologic sales too. "

Due to covid outbreak

https://www.express.co.uk/news/uk/1306662/London-news-NHS-Hillingdon-Hospital-emergency-closed-coronavirus-cases-staff-boris

Paul is a good chap. We have had some turbulence over the last few weeks but going forward, all blue skies now. A great future is building for Omega and I'm very confident we'll be heading to a pound soon.

More from Paul's email reply:

"Since then the Company announced a significant milestone for the UK RTC test development (ie design freeze) and so Omega now has even greater confidence in bringing the test to market as planned. As mentioned in the recent Company presentation, Omega has potentially a strong and consistent news flow over the coming months which will confirm not only progress with Omega's COVID opportunities but also with their core business as well. Significant news that expect would increase shareholder value would be confirmation of a supply agreement with the UK Government, followed by successful CE marking and approval of the UK RTC lateral flow product, as well as news of commercial traction for the Mologic tests. The company, and the Consortium, are working hard to deliver these."

Received a reply from Paul yesterday on whether finnCap shorted Omega. Excerpts of reply below :

"I’m happy to confirm (having discussed this with finnCap) that they have not been shorting the shares. finnCap do not run any money so they would never be able to have a material short. The market making book for finnCap is generally long of their corporate stocks, but obviously they have to sell stock from time to time (when dealing with sellers) to facilitate liquidity.



Large volumes of relatively small trades can easily move a share price considerably (up and down) and this has been seen in a lot of COVID-19 related stocks where high volumes of trading since April has driven up share prices and all of the have come back some way since peaks in May – common with all of these are the large volumes of small daily trades, indicative of a surge in retail investor interest.



Novacyt rose from 38p in April to £4.91 and are now back at £2.78

Genedrive plc rose from 30p in April to £2.20 and are now back at £1.06

Avacta rose from 23p in April to over £2 and are now back at £1.35



I can’t provide any additional timeline beyond what has already been disclosed in the announcement. Whilst timelines are not price sensitive in themselves clearly investors are very keen to know exact timelines and I believe a number of investors decided to sell shares as we approached the end of June and they feared that design freeze would fail to appear before the “end of June” timeline. If the Consortium or Omega are able to give further details of timelines that would have to be in an RNS announcement.

It’s also why the Company made available to all shareholders the recording of the presentation it gave to institutional shareholders and wealth managers so that they would have the same insight as those professional investors who chose to invest in this funding round – you can see and hear the presentation here if you haven’t seen it already: https://webcasting.brrmedia.co.uk/broadcast/5eec769f5e278421d0699138"

"I also think that finnCap have also been very supportive of smaller retail investors by making their equity research and growth forecasts for Omega available through their research portal – you should be able to do so by registering here: https://researchlibrary.finncap.com/User/Login

There’s also a link to this on the Omega website. There you can search for the 22 June research note which details the revenue and gross profit potential of lateral flow device manufacturing based on capacity utilisation. I think making this level of equity research available to all types of investors shows again a major consideration for retail investors who normally would not have access to this research, which elsewhere is made only available to institutional investors."

Ignore bullcox. He's about to be abducted by aliens and be severely probed.

I did send a nasty email to Fincap. Maybe that sppured them into 9 buying frenzy :)

I have already written. I urge others to do likewise.

Anyone going to raise a complaint?

Market Makers have to provide a 30 day exemption notice before short according to this :

Notify us to use exemption
You must notify the relevant competent authority – in the UK this is the FCA – that you are intending to use the exemption 30 days before you intend to do so.

When notifying us that your firm intends to use this exemption regarding a financial instrument, you must use our forms (see below) and provide certain evidence.

To notify us, please send the relevant forms and further information to ssrmarketmaker@fca.org.uk.

We will contact you before the 30-day period has expired to confirm whether we will prohibit the use of the exemption or not.
https://www.fca.org.uk/markets/short-selling/exemptions-requirements

Buy back to 39p. Will close at 40 and so predictable. Feel sorry for thoes who sold at a loss.

Placing money has probably already been spent in increasing production. Next week will be the beginning of news flow including product orders.

Get them at this price for only a few days. Much higher next week.

Unless he wants in cheeper.

Sam bullcox,

Great research, I don't want to steal your thunder but I think the opportunity here is truly mind blowing. The next frontier is space! There's a whole universe out there and who knows how many billions of alien life forms we can get orders from.

I nominate you as our leader to negotiate an intergalactic sales agreement. You'll be shortly beemed up and hopefully taken to a galaxy far, far away. Hopefully you'll get a real probing and come back next century with many orders.

Definitely manipulation to hold SP near placing. With news anticipation next week, we'll see a recovery back to the 60's. I bet it happens very quick, as the MMs have got plenty of shares to sell at a premium.